潜在性結核感染症（LTBI）検査の世界市場2020年：企業別、地域別、種類・用途別

• 英文タイトル：Global Latent Tuberculosis Infection (LTBI) Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：MRC2012B0626
• 出版社/出版日：GlobalInfoResearch / 2020年12月21日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、104ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

本調査レポートでは、潜在性結核感染症（LTBI）検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。潜在性結核感染症（LTBI）検査の種類別市場規模（ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA））、用途別市場規模（病院・診療所、診断研究所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Qiagen、Thermo Fisher Scientific、Sanofi、Oxford Immunotec、Bio-Rad Laboratories、Par Sterile、
・地域別グローバル市場分析 2015年-2020年
・潜在性結核感染症（LTBI）検査の北米市場（アメリカ、カナダ、メキシコ）
・潜在性結核感染症（LTBI）検査のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア）
・潜在性結核感染症（LTBI）検査のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア）
・潜在性結核感染症（LTBI）検査の南米市場（ブラジル、アルゼンチン）
・潜在性結核感染症（LTBI）検査の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ）
・種類別分析：ツベルクリン皮膚試験（TST）、インターフェロンガンマ放出アッセイ（IGRA）
・用途別分析：病院・診療所、診断研究所、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The Latent Tuberculosis Infection (LTBI) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Latent Tuberculosis Infection (LTBI) Testing market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.2%% in the forecast period of 2020 to 2025 and will expected to reach USD 1593.2 million by 2025, from USD 1301 million in 2019.

Market segmentation
Latent Tuberculosis Infection (LTBI) Testing market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Latent Tuberculosis Infection (LTBI) Testing market has been segmented into:
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)

By Application, Latent Tuberculosis Infection (LTBI) Testing has been segmented into:
Hospitals and Clinics
Diagnostic Laboratories
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Latent Tuberculosis Infection (LTBI) Testing market presented in the report. This section sheds light on the sales growth of different regional and country-level Latent Tuberculosis Infection (LTBI) Testing markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Latent Tuberculosis Infection (LTBI) Testing market.

The report offers in-depth assessment of the growth and other aspects of the Latent Tuberculosis Infection (LTBI) Testing market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Latent Tuberculosis Infection (LTBI) Testing Market Share Analysis
Latent Tuberculosis Infection (LTBI) Testing competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Latent Tuberculosis Infection (LTBI) Testing sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Latent Tuberculosis Infection (LTBI) Testing sales, revenue and market share for each player covered in this report.

The major players covered in Latent Tuberculosis Infection (LTBI) Testing are:
Qiagen
Thermo Fisher Scientific
Sanofi
Oxford Immunotec
Bio-Rad Laboratories
Par Sterile
Among other players domestic and global, Latent Tuberculosis Infection (LTBI) Testing market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

レポート目次

1 Latent Tuberculosis Infection (LTBI) Testing Market Overview
1.1 Product Overview and Scope of Latent Tuberculosis Infection (LTBI) Testing
1.2 Classification of Latent Tuberculosis Infection (LTBI) Testing by Type
1.2.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019
1.2.3 Tuberculin Skin Test (TST)
1.2.4 Interferon Gamma Released Assay (IGRA)
1.3 Global Latent Tuberculosis Infection (LTBI) Testing Market by Application
1.3.1 Overview: Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Global Latent Tuberculosis Infection (LTBI) Testing Market by Regions
1.4.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Latent Tuberculosis Infection (LTBI) Testing (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Latent Tuberculosis Infection (LTBI) Testing Status and Prospect (2015-2025)
2 Company Profiles
2.1 Qiagen
2.1.1 Qiagen Details
2.1.2 Qiagen Major Business
2.1.3 Qiagen SWOT Analysis
2.1.4 Qiagen Product and Services
2.1.5 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific SWOT Analysis
2.2.4 Thermo Fisher Scientific Product and Services
2.2.5 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi
2.3.1 Sanofi Details
2.3.2 Sanofi Major Business
2.3.3 Sanofi SWOT Analysis
2.3.4 Sanofi Product and Services
2.3.5 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
2.4 Oxford Immunotec
2.4.1 Oxford Immunotec Details
2.4.2 Oxford Immunotec Major Business
2.4.3 Oxford Immunotec SWOT Analysis
2.4.4 Oxford Immunotec Product and Services
2.4.5 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories SWOT Analysis
2.5.4 Bio-Rad Laboratories Product and Services
2.5.5 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
2.6 Par Sterile
2.6.1 Par Sterile Details
2.6.2 Par Sterile Major Business
2.6.3 Par Sterile Product and Services
2.6.4 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Latent Tuberculosis Infection (LTBI) Testing Players Market Share
3.2.2 Top 10 Latent Tuberculosis Infection (LTBI) Testing Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Regions
4.2 North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
4.3 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
4.5 South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
5 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
5.1 North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
5.2 USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
5.3 Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
5.4 Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
6 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
6.1 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
6.2 Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
6.3 UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
6.4 France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
6.5 Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
6.6 Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
7.1 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
7.2 China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
7.3 Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
7.4 Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
7.5 India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
8 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries
8.1 South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
8.2 Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
8.3 Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Latent Tuberculosis Infection (LTBI) Testing by Countries
9.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
9.2 Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
9.3 UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
9.4 Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
9.5 South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue and Market Share by Type (2015-2020)
10.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Type (2019-2024)
10.3 Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2025)
10.4 Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2025)
11 Global Latent Tuberculosis Infection (LTBI) Testing Market Segment by Application
11.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application (2015-2020)
11.2 Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Application (2019-2024)
11.3 Hospitals and Clinics Revenue Growth (2015-2020)
11.4 Diagnostic Laboratories Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2021-2025)
12.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast (2021-2025)
12.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast by Regions (2021-2025)
12.3 North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
12.4 Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
12.6 South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Latent Tuberculosis Infection (LTBI) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Qiagen Corporate Information, Location and Competitors
Table 7. Qiagen Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 8. Qiagen Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)
Table 9. Qiagen SWOT Analysis
Table 10. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 11. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Thermo Fisher Scientific Corporate Information, Location and Competitors
Table 13. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 14. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2018-2019)
Table 15. Thermo Fisher Scientific SWOT Analysis
Table 16. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 17. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Sanofi Corporate Information, Location and Competitors
Table 19. Sanofi Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 20. Sanofi Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)
Table 21. Sanofi SWOT Analysis
Table 22. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 23. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Oxford Immunotec Corporate Information, Location and Competitors
Table 25. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 26. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)
Table 27. Oxford Immunotec SWOT Analysis
Table 28. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 29. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Bio-Rad Laboratories Corporate Information, Location and Competitors
Table 31. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 32. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)
Table 33. Bio-Rad Laboratories SWOT Analysis
Table 34. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 35. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Par Sterile Corporate Information, Location and Competitors
Table 37. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Major Business
Table 38. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Total Revenue (USD Million) (2017-2018)
Table 39. Par Sterile SWOT Analysis
Table 40. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product and Solutions
Table 41. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Players (2015-2020)
Table 43. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players (2015-2020)
Table 44. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Regions (2015-2020)
Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2015-2020)
Table 46. North America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
Table 47. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Table 48. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)
Table 50. South America Latent Tuberculosis Infection (LTBI) Testing Revenue by Countries (2015-2020)
Table 51. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Table 54. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) by Type (2015-2020)
Table 55. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)
Table 56. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Type (2021-2025)
Table 57. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Application (2015-2020)
Table 58. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)
Table 59. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Forecast by Application (2021-2025)
Table 60. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Picture
Figure 2. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Type in 2019
Figure 3. Tuberculin Skin Test (TST) Picture
Figure 4. Interferon Gamma Released Assay (IGRA) Picture
Figure 5. Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Application in 2019
Figure 6. Hospitals and Clinics Picture
Figure 7. Diagnostic Laboratories Picture
Figure 8. Others Picture
Figure 9. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2019
Figure 18. Global Top 10 Players Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions (2015-2020)
Figure 22. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Regions in 2018
Figure 23. North America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 24. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 26. South America Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 28. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Figure 29. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019
Figure 30. USA Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 31. Canada Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 33. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019
Figure 35. Germany Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 36. UK Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 37. France Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 38. Russia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 39. Italy Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019
Figure 42. China Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 43. Japan Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 44. Korea Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 45. India Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 47. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Figure 48. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019
Figure 49. Brazil Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 54. UAE Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Latent Tuberculosis Infection (LTBI) Testing Revenue and Growth Rate (2015-2020)
Figure 57. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type (2015-2020)
Figure 58. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Type in 2019
Figure 59. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Type (2021-2025)
Figure 60. Global Tuberculin Skin Test (TST) Revenue Growth Rate (2015-2020)
Figure 61. Global Interferon Gamma Released Assay (IGRA) Revenue Growth Rate (2015-2020)
Figure 62. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application (2015-2020)
Figure 63. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Share by Application in 2019
Figure 64. Global Latent Tuberculosis Infection (LTBI) Testing Market Share Forecast by Application (2021-2025)
Figure 65. Global Hospitals and Clinics Revenue Growth Rate (2015-2020)
Figure 66. Global Diagnostic Laboratories Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Latent Tuberculosis Infection (LTBI) Testing Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
Figure 72. Europe Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
Figure 74. South America Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Latent Tuberculosis Infection (LTBI) Testing Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel

以下、関連資料のご紹介

DNA診断/検査の世界市場2020年：企業別、地域別、種類・用途別

MRC2012B0277 2020年12月21日 104Pages
本調査レポートでは、DNA診断/検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。DNA診断/検査の種類別市場規模（PCRベース診断、NGS DNA診断、インサイチュ（In-situ）ハイブリダイゼーション診断、マイクロアレイベース診断）、用途別市場規模（腫瘍診断・組織病理、アイデ...

性感染症（STD）検査の世界市場2020年：企業別、地域別、種類・用途別

Global Sexually Transmitted Diseases Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B1382 2020年12月28日 103Pages
本調査レポートでは、性感染症（STD）検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。性感染症（STD）検査の種類別市場規模（クラミジア検査、淋病検査、梅毒検査、HIV検査、HSV検査、HPV検査、軟性下疳検査、その他）、用途別市場規模（クリニック、病院、その他）、地域別市場規模...

防火システムテスト・検査の世界市場2020年：企業別、地域別、種類・用途別

MRC2012B0788 2020年12月24日 102Pages
本調査レポートでは、防火システムテスト・検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。防火システムテスト・検査の種類別市場規模（火災警報・検知システム、消火システム、スプリンクラーシステム、カードアクセスシステム、その他）、用途別市場規模（データセンター、製造、通信、冷凍倉庫、...

呼吸器合胞体ウイルス（RSV）検査の世界市場2020年：企業別、地域別、種類・用途別

Global Respiratory Syncytial Virus (RSV) Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B1310 2020年12月28日 105Pages
本調査レポートでは、呼吸器合胞体ウイルス（RSV）検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。呼吸器合胞体ウイルス（RSV）検査の種類別市場規模（テストサービス、テストキット、その他）、用途別市場規模（病院、POCT、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

血液感染検査の世界市場2020年：企業別、地域別、種類・用途別

MRC2012B0136 2020年12月21日 106Pages
本調査レポートでは、血液感染検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。血液感染検査の種類別市場規模（医療機器、検出試薬）、用途別市場規模（病院、診療所、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカな...

菌血症検査の世界市場2020年：企業別、地域別、種類・用途別

Global Bloodstream Infection Testing Market 2020 by Company, Regions, Type and Application, Forecast to 2025
MRC2012B0138 2020年12月21日 103Pages
本調査レポートでは、菌血症検査の世界市場を広く調査・分析し、今後の市場展望をまとめております。菌血症検査の種類別市場規模（医療機器、検出試薬）、用途別市場規模（病院、診療所、医療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）...

菌血症検査の世界市場（～2026年）

Global Blood Stream Infection Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY11137 2020年11月25日 97Pages
当調査資料は菌血症検査のグローバル市場について調査・分析したレポートです。種類別（従来型血液培養検査、PCR法、核酸検査、質量分析、ポイントオブケア検査（POCT））市場規模、用途別（病院、独立診断センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリ...

感染性胃腸炎検査の世界市場（～2026年）

Global Gastrointestinal Infection Testing Market Size, Status and Forecast 2020-2026
MRC2-11QY12009 2020年11月25日 127Pages
当調査資料は感染性胃腸炎検査のグローバル市場について調査・分析したレポートです。種類別（ウイルス性胃腸感染症、細菌性胃腸感染症、寄生虫性胃腸感染症）市場規模、用途別（病院、画像診断センター・研究所、外来手術センター、学術機関、研究センター・組織）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイ...

結核（TB）診断の世界市場（～2026年）

Global Tuberculosis (TB) Diagnostics Market Size, Status and Forecast 2020-2026
MRC2-11QY04901 2020年11月20日 96Pages
当調査資料は結核（TB）診断のグローバル市場について調査・分析したレポートです。種類別（塗抹顕微鏡検査、分子検査、マントーツベルクリン検査、培養、薬剤感受性検査、PLHIV用LF-LAM）市場規模、用途別（診断研究所、病院）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス...

結核治療の世界市場（～2026年）

Global Tuberculosis Treatment Market Size, Status and Forecast 2020-2026
MRC2-11QY04903 2020年11月20日 92Pages
当調査資料は結核治療のグローバル市場について調査・分析したレポートです。種類別（活動性結核、潜在性結核）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、...

菌血症検査の世界市場（～2026年） BSIs occur when any causative organism enters the bloodstream through a wound, injection, or during a surgical procedure. BSI testing is done to detect the cause of these infections. Bloodstream infections are mostly diagnosed by blood culture tests and molecular tests. Commercially available tests …
結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…
感染性胃腸炎検査の世界市場（～2026年） Gastrointestinal infection is the most common type of infection encountered in patient populations. These infections are not always severe but they often resolve rapidly on their own without any treatment. Growing adoption of technologically advanced molecular techniques and rising incidence of gast…
血液感染検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Blood Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…
菌血症検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Bloodstream Infection Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…